Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

THIO Sequenced With Cemiplimab in Advanced NSCLC

NCT05208944

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Summit Health Florham Park, New Jersey, United States
  • Sunshine Coast Haematology and Oncology Clinic Buderim, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View all 35 locations
View Trial Details
Active, Not Recruiting

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

NCT02453282

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Yuma, Arizona, United States
  • Research Site Bakersfield, California, United States
View all 196 locations
View Trial Details
Active, Not Recruiting

A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC

NCT03819465

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Iowa City, Iowa, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Nashville, Tennessee, United States
  • Research Site Salzburg, Austria
View all 41 locations
View Trial Details
Active, Not Recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06162572

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Loma Linda University Loma Linda, California, United States
  • Henry Ford Health Detroit, Michigan, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View all 63 locations
View Trial Details
Active, Not Recruiting

A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06448312

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hebei University Affiliated Hospital Baoding, China
  • Beijing Chest Hospital. Capital Medical University Beijing, China
  • Beijing Institute for Cancer Research Beijing, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
View all 64 locations
View Trial Details

Related conditions